Increasing Scope Of Nano-Insecticides
Nanotechnology and nanoparticles are being used by toxicologists and horticulturists all over the world to produce modern, environmentally safe insecticides. Pharmaceuticals, medical devices, and chemical companies have all been transformed by nanoparticles. Since a large number of insecticides are non-toxic, most engineers agree that nanotechnology can help make them safer. Furthermore, insecticides can be made more effective with proper research and development, resulting in a substantial reduction in the amount of insecticides sprayed on agricultural fields.
Intensive Farming Techniques
Pesticide demand is increasing as farmers around the world implement intensive farming techniques to increase production per hectare. This type of farming is a form of agricultural intensification and mechanisation that aims to maximise yields from available land by using pesticides and chemical fertilisers in large quantities. These strategies aid in meet
· EBITDA at £6.7m (2019 restated : £1.7m) · Profit before taxation of £4.5m (2019 restated profit : £1.1m) · Profit after taxation of £3.9m (2019 restated profit : £1.3m) · Earnings per share of 3.13p (2019: restated Earnings per share : 1.68p) · Cash generated by operations of £3.5m (2019 restated : £1.3m) · Net cash at 30th September 2020 of £12.9m (2019: £13.4m) Prior period figures have been restated to reflect adjustments arising from the March 2020 audit. Operations · USA recovery following the easing in geopolitical trade tensions between China and the USA · Latin America performing strongly, led by Brazil · New marketing authorisation from the European Medicines Agency for the use of Aivlosin® 625 mg/g Water Soluble Granules in pigs for the treatment of Mycoplasma hyopneumoniae
NPB Approval gives Aivlosin WSG the broadest label indication of any product for the control of swine respiratory disease.
Feb 02, 2021
In January 2021, the FDA’s Center for Veterinary Medicine, as well as the Veterinary Drugs Directorate of Health Canada, added
Mycoplasma hyopneumoniae to the approved label indications for Aivlosin (
tylvalosin) Water Soluble Granules (WSG).
“This approval gives Aivlosin WSG the broadest label indication of any product for the control of swine respiratory disease (SRD),” said Dr. Chad Smith, U.S. technical service veterinarian for Pharmgate. “
M. hyo is a primary pathogen in swine respiratory disease complexes and plays an important role in facilitating the entry of bacterial and viral pathogens. Aivlosin WSG is competitive economically compared to other protocols on a per-pig basis. Veterinarians and producers can be confident they are making a responsible antibiotic choice to control SRD.”